Artificial intelligence drug discovery company Recursion Pharmaceuticals has announced an oversubscribed Series D funding round totaling $239 million. Headlining the raise is...
When CEO Jeff LeBrun and CTO Chuks Onwuneme co-founded optimize.health back in 2015, the startup was focused on medication adherence. Their first...